Share This Article:

Evidence-Based Medicine of Screening of Diabetic Retinopathy among Type 2 Diabetes: A Clinical Overview

Abstract Full-Text HTML XML Download Download as PDF (Size:328KB) PP. 873-883
DOI: 10.4236/health.2015.77103    3,079 Downloads   3,859 Views   Citations

ABSTRACT

Diabetic retinopathy (DR) is a well-characterized chronic ocular disorder that developed in nearly all diabetic patients in the long run. The knowledge of DR is crucial to manage this disorder when planning screening and preventive programs and identifying the appropriated therapeutic strategies among. Expectant management may represent a valid therapeutic approach depending upon the clinical manifestations of the disease and, in particular, on the changes over time. If early treatment of DR reduces the probability of severe stage or slows the progression of blindness, it might sufficiently reduce treatment costs in later years to offset the costs of screening and early treatment. In addition, whether screening for DR is worthwhile is contingent on whether subjects are willing to pay the eye screening program that would decrease the risk of photocoagulation. In this review we discuss epidemiology, management, and economic evaluation of screening of DR among type 2 diabetes.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Lin, Y. , Chen, Y. , Peng, Y. , Chen, L. , Liu, J. , Chen, F. and Tung, T. (2015) Evidence-Based Medicine of Screening of Diabetic Retinopathy among Type 2 Diabetes: A Clinical Overview. Health, 7, 873-883. doi: 10.4236/health.2015.77103.

References

[1] Ruta, L.M., Magliano, D.J., LeMesurier, R., Taylor, H.R., Zimmet, P.Z. and Shaw, J.E. (2013) Prevalence of Diabetic Retinopathy in Type 2 Diabetes in Developing and Developed Countries. Diabetic Medicine, 30, 387-398.
http://dx.doi.org/10.1111/dme.12119
[2] Szabo, S.M., Beusterien, K.M., Pleil, A.M., et al. (2010) Patient Preferences for Diabetic Retinopathy Health States. Investigative Ophthalmology & Visual Science, 51, 3387-3394.
http://dx.doi.org/10.1167/iovs.09-4194
[3] Lin, J.D., Shieh, W.B., Huang, M.J. and Huang, H.-S. (1993) Diabetes Mellitus and Hypertension Based on the Family History and 2-h Postprandial Blood Sugar in the Ann-Lo District (Northern Taiwan). Diabetes Research and Clinical Practice, 20, 75-85.
http://dx.doi.org/10.1016/0168-8227(93)90026-2
[4] Li, C.L., Tsai, S.T. and Chou, P. (1999) Comparison of the Results between Two Diagnostic Criteria by ADA and WHO among Subjects with FPG 5.6-7.8 mmol/l in Kin-Hu and Kin-Chen, Kinmen, 1991-94. Diabetes Research and Clinical Practice, 45, 51-59.
http://dx.doi.org/10.1016/S0168-8227(99)00050-9
[5] Chou, P., Liao, M.J., Kuo, H.S., Hsiao, K.J. and Tsai, S.T. (1994) A Population Survey on the Prevalence of Diabetes in Kin-Hu, Kinmen. Diabetes Care, 17, 1055-1058.
http://dx.doi.org/10.2337/diacare.17.9.1055
[6] Chou, P., Li, C.L., Kuo, H.S., Hsiao, K.J. and Tsai, S.T. (1997) Comparison of the Prevalence of Two Diabetes Surveys in Pu-Li, Taiwan, 1987-1988 and 1991-1992. Diabetes Research and Clinical Practice, 38, 61-67.
http://dx.doi.org/10.1016/S0168-8227(97)00091-0
[7] Chen, H.D., Shaw, C.K., Tseng, W.P., Chen, H.I. and Lee, M.L. (1997) Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Aborigines and Chinese in Eastern Taiwan. Diabetes Research and Clinical Practice, 38, 199-205.
http://dx.doi.org/10.1016/S0168-8227(97)00104-6
[8] Lu, F.H., Yang, Y.C., Wu, J.S., Wu, C.H. and Chang, C.J. (1998) A Population-Based Study of the Prevalence and Associated Factors of Diabetes Mellitus in Southern Taiwan. Diabetic Medicine, 15, 564-572.
http://dx.doi.org/10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H
[9] Chen, K.T., Chen, C.J., Gregg, E.W., Williamson, D.F. and Narayan, K.M.V. (1999) High Prevalence of Impaired Fasting Glucose and Type 2 Diabetes Mellitus in Penghu Islets, Taiwan: Evidence of a Rapidly Emerging Epidemic? Diabetes Research and Clinical Practice, 44, 59-69.
http://dx.doi.org/10.1016/S0168-8227(99)00025-X
[10] Chen, S.J., Chou, P., Lee, A.F., et al. (2010) Microaneurysm Number and Distribution in the Macula of Chinese Type 2 Diabetics with Early Diabetic Retinopathy: A Population-Based Study in Kinmen, Taiwan. Acta Diabetologica, 47, 35-41.
[11] Rein, D.B., Wittenborn, J.S., Zhang, X., et al. (2011) The Cost-Effectiveness of Three Screening Alternatives for People with Diabetes with No or Early Diabetic Retinopathy. Health Services Research, 46, 1534-1561.
http://dx.doi.org/10.1111/j.1475-6773.2011.01263.x
[12] Chen, J.Y., Tsai, S.T., Hsu, C.T., et al. (2013) Cost-Benefit Analysis of Screening for Gallstone Disease among Chinese Population in Taiwan. The Open Access Journal of Science and Technology, 1, 1-7.
http://dx.doi.org/10.11131/2013/100002
[13] Stitt, A.W., Gardiner, T.A. and Archer, D.B. (1995) Histological and Ultrastructural Investigation of Retinal Microaneurysm Development in Diabetic Patients. The British Journal of Ophthalmology, 79, 362-367.
[14] Frank, R.N. (2004) Diabetic Retinopathy. The New England Journal of Medicine, 350, 48-58.
http://dx.doi.org/10.1056/NEJMra021678
[15] Ruberte, J., Ayuso, E., Navarro, M., et al. (2004) Increased Ocular Levels of IGF-1 in Transgenic Mice Lead to Diabetes-Like Eye Disease. The Journal of Clinical Investigation, 113, 1149-1157.
http://dx.doi.org/10.1172/JCI19478
[16] Aiello, L.P. (2005) Angiogenic Pathways in Diabetic Retinopathy. The New England Journal of Medicine, 353, 839- 841.
http://dx.doi.org/10.1056/NEJMe058142
[17] Aiello, L.P., Davis, M.D., Girach, A., et al. (2006) Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy. Ophthalmology, 113, 2221-2230.
http://dx.doi.org/10.1016/j.ophtha.2006.07.032
[18] PKC-DMES Study Group (2007) Effect of Ruboxistaurin in Patients with Diabetic Macular Edema: Thirty-Month Results of the Randomized PKC-DMES Clinical Trial. Archives of Ophthalmology, 125, 318-324.
http://dx.doi.org/10.1001/archopht.125.3.318
[19] Grover, D., Li, T.J. and Chong, C.C. (2008) Intravitreal Steroids for Macular Edema in Diabetes. Cochrane Database of Systematic Reviews, No. 1, Article No. CD005656.
[20] Yilmaz, T., Weaver, C.D, Gallagher, M.J., et al. (2009) Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema: A Systematic Review. Ophthalmology, 116, 902-911.
http://dx.doi.org/10.1016/j.ophtha.2009.02.002
[21] Nishikawa, T., Edelstein, D., Du, X.L., et al. (2000) Normalizing Mitochondrial Superoxide Production Blocks Three Pathways of Hyperglycaemic Damage. Nature, 404, 787-790.
http://dx.doi.org/10.1038/35008121
[22] Lonn, E., Yusuf, S., Hoogwerf, B., et al. (2002) Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients with Diabetes: Results of the HOPE Study and MICRO-HOPE Substudy. Diabetes Care, 25, 1919-1927.
http://dx.doi.org/10.2337/diacare.25.11.1919
[23] Gao, B.B., Clermont, A., Rook, S., et al. (2007) Extracellular Carbonic Anhydrase Mediates Hemorrhagic Retinal and Cerebral Vascular Permeability through Prekallikrein Activation. Nature Medicine, 13, 181-188.
http://dx.doi.org/10.1038/nm1534
[24] Bolton, W.K., Cattran, D.C., Williams, M.E., et al. (2004) Randomized Trial of an Inhibitor of Formation of Advanced Glycation end Products in Diabetic Nephropathy. American Journal of Nephrology, 24, 32-40.
http://dx.doi.org/10.1159/000075627
[25] Early Treatment Diabetic Retinopathy Study Research Group (1991) Early Photocoagulation for Diabetic Retinopathy: ETDRS Report Number 9. Ophthalmology, 98, 766-785.
http://dx.doi.org/10.1016/S0161-6420(13)38011-7
[26] Wilkinson, C.P., Ferris, F.L., Klein, R.E., Lee, P.P., Agardh, C.D., Davis, M., et al. (2003) Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology, 110, 1677-1682.
http://dx.doi.org/10.1016/S0161-6420(03)00475-5
[27] Aiello, L.M. (2003) Perspectives on Diabetic Retinopathy. American Journal of Ophthalmology, 136, 122-135.
http://dx.doi.org/10.1016/S0002-9394(03)00219-8
[28] Ekoe, J.M., Zimmet, P. and Williams, R. (2001) The Epidemiology of Diabetes Mellitus: An International Perspective. John Wiley & Sons, Inc., Hoboken.
[29] Al-Rubeaan, K., Abu El-Asrar, A.M., Youssef, A.M., et al. (2014) Diabetic Retinopathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study. Acta Ophthalmologica, 93, e140-e147.
[30] Li, L., Ji, L., Guo, X., et al. (2014) Prevalence of Microvascular Diseases among Tertiary Care Chinese with Early versus Late Onset of Type 2 Diabetes. Journal of Diabetes and its Complications, 29, 32-37.
[31] Costanian, C., Bennett, K., Hwalla, N., et al. (2014) Prevalence, Correlates and Management of Type 2 Diabetes Mellitus in Lebanon: Findings from a National Popula-tion-Based Study. Diabetes Research and Clinical Practice, 105, 408-415.
http://dx.doi.org/10.1016/j.diabres.2014.06.005
[32] Collier, A., Ghosh, S., Hair, M., et al. (2014) Gender Differences and Patterns of Cardiovascular Risk Factors in Type 1 and Type 2 Diabetes: A Population-Based Analysis from a Scottish Region. Diabetic Medicine, 23, 42-46.
[33] Thomas, R.L., Dunstan, F.D., Luzio, S.D., et al. (2014) Prevalence of Diabetic Retinopathy within a National Diabetic Retinopathy Screening Service. British Journal of Ophthalmology, 99, 64-68.
[34] Cander, S., Coban, S., Altuner, S., et al. (2014) Prevalence and Correlates of Erectile Dysfunction in Type 2 Diabetes Mellitus: A Cross-Sectional Single-Center Study among Turkish Patients. Metabolic Syndrome and Related Disor-ders, 12, 324-329.
http://dx.doi.org/10.1089/met.2013.0150
[35] Sosale, A., Prasanna Kumar, K.M., Sadikot, S.M., et al. (2014) Chronic Complications in Newly Diagnosed Patients with Type 2 Diabetes Mellitus in India. Indian Journal of Endocrinology and Metabolism, 18, 355-360.
http://dx.doi.org/10.4103/2230-8210.131184
[36] Olafsdottir, E., Andersson, D.K., Dedorsson, I., et al. (2014) The Prevalence of Retinopathy in Subjects with and without Type 2 Diabetes Mellitus. Acta Ophthalmologica, 92, 133-137.
http://dx.doi.org/10.1111/aos.12095
[37] Jingi, A.M., Noubiap, J.J., El-long, A., et al. (2014) Epidemiology and Treatment Outcomes of Diabetic Retinopathy in a Diabetic Population from Cameroon. BMC Ophthalmology, 14, 19.
http://dx.doi.org/10.1186/1471-2415-14-19
[38] Sunita, M., Desai, S., Vinay, P., et al. (2014) Aditya Jyot-Diabetic Retinopathy in Urban Mumbai Slums Study (AJ- DRUMSS): Study Design and Methodolo-gy—Report 1. Ophthalmic Epidemiology, 21, 51-60.
http://dx.doi.org/10.3109/09286586.2013.867509
[39] Almdal, T.P., Handlos, L.N., Valerius, M., et al. (2014) Glycaemic Threshold for Diabetes-Specific Retinopathy among Individuals from Saudi Arabia, Algeria and Portugal. Diabetes Research and Clinical Practice, 103, e44-e46.
http://dx.doi.org/10.1016/j.diabres.2013.12.023
[40] Schellini, S.A., Carvalho, G.M., Rendeiro, F.S., et al. (2014) Prevalence of Diabetes and Diabetic Retinopathy in a Brazilian Population. Ophthalmic Epidemiology, 21, 33-38.
http://dx.doi.org/10.3109/09286586.2013.868004
[41] Win Tin, S.T., Kenilorea, G., Gadabu, E., et al. (2014) The Prevalence of Diabetes Complications and Associated Risk Factors in Pacific Islands Countries. Diabetes Research and Clinical Practice, 103, 114-1148.
http://dx.doi.org/10.1016/j.diabres.2013.09.017
[42] Ghassibe-Sabbagh, M., Deeb, M., Salloum, A.K., et al. (2014) Multivariate Epidemiologic Analysis of Type 2 Diabetes Mellitus Risks in the Lebanese Population. Diabetology & Metabolic Syndrome, 6, 89.
http://dx.doi.org/10.1186/1758-5996-6-89
[43] Rajalakshmi, R., Amutha, A., Ranjani, H., et al. (2014) Prevalence and Risk Factors for Diabetic Retinopathy in Asian Indians with Young Onset Type 1 and Type 2 Diabetes. Journal of Diabetic Complications, 28, 291-297.
http://dx.doi.org/10.1016/j.jdiacomp.2013.12.008
[44] Liu, L., Geng, J., Wu, J., et al. (2013) Prevalence of Ocular Fundus Pathology with Type 2 Diabetes in a Chinese Urban Community as Assessed by Telescreening. BMJ Open, 3, e004146.
http://dx.doi.org/10.1136/bmjopen-2013-004146
[45] Simic, I., Pecin, I., Tedeschi-Reiner, E., et al. (2013) Risk Factors for Microvascular Atherosclerotic Changes in Patients with Type 2 Diabetes Mellitus. Collegium Antropologicum, 37, 783-787.
[46] Li, N., Yang, X.F., Deng, Y., et al. (2013) Diabetes Self-Management and Its Association with Diabetic Retinopathy in Patients with Type 2 Diabetes. Chinese Journal of Ophthalmology, 49, 500-506.
[47] Ramavat, P.R., Ramavat, M.R., Ghugare, B.W., et al. (2013) Prevalence of Diabetic Retinopathy in Western Indian Type 2 Diabetic Population: A Hospital-Based Cross-Sectional Study. Journal of Clinical and Diagnostic Research, 7, 1387-1390.
http://dx.doi.org/10.7860/jcdr/2013/5259.3146
[48] Potisat, S., Krairittichai, U., Jongsareejit, A., et al. (2013) A 4-Year Prospective Study on Long-Term Complications of Type 2 Diabetic Patients: The Thai DMS Diabetes Complications (DD.Comp.) Project. Journal of the Medical Association of Thailand, 96, 637-643.
[49] Tan, E.D., Davis, W.A. and Davis, T.M. (2013) Characteristics and Prognosis of Asian Patients with Type 2 Diabetes from a Multi-Racial Australian Community: The Fremantle Diabetes Study. Internal Medicine Journal, 43, 1125-1132.
http://dx.doi.org/10.1111/imj.12246
[50] Islam, S., Harnarayan, P., Cawich, S.O., et al. (2013) Epidemiology of Diabetic Foot Infections in an Eastern Caribbean Population: A Prospective Study. The Permanente Journal, 17, 37-40.
http://dx.doi.org/10.7812/TPP/12-126
[51] TODAY Study Group (2013) Retinopathy in Youth with Type 2 Diabetes Participating in the TODAY Clinical Trial. Diabetes Care, 36, 1772-1174.
http://dx.doi.org/10.2337/dc12-2387
[52] Mohan, V., Shanthi Rani, C.S., Amutha, A., et al. (2013) Clinical Profile of Long-Term Survivors and Nonsurvivors with Type 2 Diabetes. Diabetes Care, 36, 2190-2197.
http://dx.doi.org/10.2337/dc12-1193
[53] McHugh, S., Buckley, C. and Murphy, K. (2013) Quality-Assured Screening for Diabetic Retinopathy Delivered in Primary Care in Ireland: An Observational Study. British Journal of General Practice, 63, e134-e140.
http://dx.doi.org/10.3399/bjgp13X663091
[54] Mosenzon, O., Raz, I., Scirica, B.M., et al. (2013) Base-line Characteristics of the Patient Population in the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 Trial. Diabetes/ Metabolism Research and Reviews, 29, 417-426.
http://dx.doi.org/10.1002/dmrr.2413
[55] Tanaka, S., Tanaka, S., Iimuro, S., et al. (2013) Predicting Macro-and Microvascular Complications in Type 2 Diabetes: The Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial Risk Engine. Diabetes Care, 36, 1193-1199.
http://dx.doi.org/10.2337/dc12-0958
[56] Bertram, M.Y., Jaswal, A.V. and Van Wyk, V.P. (2013) The Non-Fatal Disease Burden Caused by Type 2 Diabetes in South Africa, 2009. Glob Health Action, 6, 19244.
http://dx.doi.org/10.3402/gha.v6i0.19244
[57] Jammal, H., Khader, Y., Alkhatib, S., et al. (2013) Diabetic Retinopathy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Jordan: Prevalence and Associated Factors. Journal of Diabetes, 5, 172-179.
http://dx.doi.org/10.1111/1753-0407.12015
[58] Kostev, K. and Rathmann, W. (2013) Diabetic Retinopathy at Diagnosis of Type 2 Diabetes in the UK: A Database Analysis. Diabetologia, 56, 109-111.
http://dx.doi.org/10.1007/s00125-012-2742-7
[59] Thomas, R.L., Distiller, L., Luzio, S.D., et al. (2013) Ethnic Differences in the Prevalence of Diabetic Retinopathy in Persons with Diabetes When First Presenting at a Diabetes Clinic in South Africa. Diabetes Care, 36, 336-341.
http://dx.doi.org/10.2337/dc12-0683
[60] Ai Ghamdi, A.H., Rabiu, M., Hajar, S., et al. (2012) Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Taif, Saudi Arabia. British Journal of Ophthalmology, 96, 1168-1172.
http://dx.doi.org/10.1136/bjophthalmol-2012-301874
[61] Glover, S.J., Burgess, P.I., Cohen, D.B., et al. (2012) Prevalence of Diabetic Retinopathy, Cataract and Visual Impairment in Patients with Diabetes in Sub-Saharan Africa. British Journal of Ophthalmology, 96, 156-161.
http://dx.doi.org/10.1136/bjo.2010.196071
[62] Gunnlaugsdottir, E., Halldorsdottir, S., Klein, R., et al. (2012) Retinopathy in Old Persons with and without Diabetes Mellitus: The Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-R). Diabetologia, 55, 671-680.
http://dx.doi.org/10.1007/s00125-011-2395-y
[63] Polack, S., Yorston, D., López-Ramos, A., et al. (2012) Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, Mexico. Ophthalmology, 119, 1033-1140.
http://dx.doi.org/10.1016/j.ophtha.2011.11.002
[64] Sáles, C.S., Lee, R.Y., Agadzi, A.K., et al. (2012) Prevalence of Diabetes Mellitus and Diabetic Retinopathy in Filipino vs Caucasian Americans: A Retrospective Cross-Sectional Epidemiologic Study of Two Convenience Samples. Ethnicity & Disease, 22, 459-465.
[65] Elhwuegi, A.S., Darez, A.A., Langa, A.M., et al. (2012) Cross-Sectional Pilot Study about the Health Status of Diabetic Patients in City of Misurata, Libya. African Health Sciences, 12, 81-86.
[66] Doucet, J., Le Floch, J.P., Bauduceau, B., et al. (2012) GERODIAB: Glycaemic Control and 5-Year Morbidity/Mortality of Type 2 Diabetic Patients Aged 70 Years and Older: 1. Description of the Population at Inclusion. Diabetes & Metabolism, 38, 523-530.
http://dx.doi.org/10.1016/j.diabet.2012.07.001
[67] Pugliese, G., Solini, A., Zoppini, G., et al. (2012) High Prevalence of Advanced Retinopathy in Patients with Type 2 Diabetes from the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Research and Clinical Practice, 98, 329-337.
http://dx.doi.org/10.1016/j.diabres.2012.09.006
[68] Zheng, Y., Lamoureux, E.L., Ikram, M.K., et al. (2012) Impact of Migration and Acculturation on Prevalence of Type 2 Diabetes and Related Eye Complications in Indians Living in a Newly Urbanised Society. PLoS ONE, 7, e34829.
http://dx.doi.org/10.1371/journal.pone.0034829
[69] Sivaprasad, S., Gupta, B., Gulliford, M.C., et al. (2012) Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK). PLoS ONE, 7, e32182.
http://dx.doi.org/10.1371/journal.pone.0032182
[70] Harris, M.I., Eastman, R.C., Cowie, C.C., et al. (1999) Racial and Ethnic Differences in Glycemic Control of Adults with Type 2 Diabetes. Diabetes Care, 22, 403-408.
http://dx.doi.org/10.2337/diacare.22.3.403
[71] McBean, A.M., Li, S., Gilbertson, D.T., et al. (2004) Differences in Diabetes Prevalence, Incidence, and Mortality among the Elderly of Four Racial/Ethnic Groups: Whites, Blacks, Hispanics, and Asians. Diabetes Care, 27, 2317-2324.
http://dx.doi.org/10.2337/diacare.27.10.2317
[72] LaVeist, T.A., Thorpe Jr., R.J., Galarraga, J.E., et al. (2009) Environmental and Socio-Economic Factors as Contributors to Racial Disparities in Diabetes Prevalence. Journal of General Internal Medicine, 24, 1144-1148.
http://dx.doi.org/10.1007/s11606-009-1085-7
[73] Janghorbani, M., Jones, R.B. and Allison, S.P. (2000) Incidence of and Risk Factors for Proliferative Retinopathy and Its Association with Blindness among Diabetes Clinic Attenders. Ophthalmic Epidemiology, 7, 225-241.
http://dx.doi.org/10.1076/opep.7.4.225.4171
[74] Janghorbani, M., Jones, R.B., Murray, K.J., et al. (2001) Incidence of and Risk Factors for Diabetic Retinopathy in Diabetic Clinic Attenders. Ophthalmic Epidemiology, 8, 309-325.
[75] Stratton, I.M., Kohner, E.M., Aldington, S.J., et al. (2001) UKPDS 50: Risk Factors for Incidence and Progression of Retinopathy in Type II Diabetes over 6 Years from Diagnosis. Diabetologia, 44, 156-163.
http://dx.doi.org/10.1007/s001250051594
[76] Lin, J.C., Shau, W.Y. and Lai, M.S. (2014) Sex- and Age-Specific Prevalence and Incidence Rates of Sight-Threaten ing Diabetic Retinopathy in Taiwan. JAMA Ophthalmology, 132, 922-928.
http://dx.doi.org/10.1001/jamaophthalmol.2014.859
[77] Xu, J., Xu, L., Wang, Y.X., et al. (2014) Ten-Year Cumulative Incidence of Diabetic Retinopathy. The Beijing Eye Study 2001/2011. PLoS ONE, 9, e111320.
http://dx.doi.org/10.1371/journal.pone.0111320
[78] Jin, P., Peng, J., Zou, H., et al. (2014) The 5-Year Onset and Regression of Diabetic Retinopathy in Chinese Type 2 Diabetes Patients. PLoS ONE, 9, e113359.
http://dx.doi.org/10.1371/journal.pone.0113359
[79] Salinero-Fort, M.á., San Andrés-Rebollo, F.J. and de Burgos-Lunar, C. (2013) Four-Year Incidence of Diabetic Retinopathy in a Spanish Cohort: The MADIABETES Study. PLoS ONE, 8, e76417.
http://dx.doi.org/10.1371/journal.pone.0076417
[80] Ahmed, K.R., Karim, M.N., Bhowmik, B., et al. (2012) Incidence of Diabetic Retinopathy in Bangladesh: A 15-Year Follow-Up Study. Journal of Diabetes, 4, 386-391.
http://dx.doi.org/10.1111/j.1753-0407.2012.00208.x
[81] Jones, C.D., Greenwood, R.H., Misra, A., et al. (2012) Incidence and Progression of Diabetic Retinopathy during 17 Years of a Population-Based Screening Program in England. Diabetes Care, 35, 592-596.
http://dx.doi.org/10.2337/dc11-0943
[82] Kawasaki, R., Tanaka, S., Tanaka, S., et al. (2011) Incidence and Progression of Diabetic Retinopathy in Japanese Adults with Type 2 Diabetes: 8 Year Follow-Up Study of the Japan Diabetes Complications Study (JDCS). Diabetologia, 54, 2288-2294.
http://dx.doi.org/10.1007/s00125-011-2199-0
[83] Tung, T.H., Chen, S.J., Liu, J.H., et al. (2005) A Community-Based Follow-Up Study on Diabetic Retinopathy among Type 2 Diabetics in Kinmen. European Journal of Epidemiology, 20, 317-323.
http://dx.doi.org/10.1007/s10654-004-6651-z
[84] Diabetic Retinopathy Study Research Group (1981) Design, Methods, and Baseline Results: DRS Report No. 6. Investigative Ophthalmology, 21, 149-209.
[85] Early Treatment Diabetic Retinopathy Study Group (1985) Photocoagulation for Diabetic Macular Edema. ETDRS Report Number 1. Archives of Ophthalmology, 103, 1796-1806.
[86] The Diabetic Retinopathy Vitrectomy Study Research Group (1985) Early Vitrectomy for Severe Vitreous Hemorrhage in Diabetic Retinopathy: Two-Year Results of a Randomized Trial. DRVS Report No. 2. Archives of Ophthalmology, 103, 1644-1652.
http://dx.doi.org/10.1001/archopht.1985.01050110038020
[87] The DCCT Research Group (1986) The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase. Diabetes, 35, 530-545.
http://dx.doi.org/10.2337/diab.35.5.530
[88] Liu, W.J., Lee, L.T., Yen, M.F., et al. (2003) Assessing Progression and Efficacy of Treatment for Diabetic Retinopathy Following the Proliferative Pathway to Blindness: Implication for Diabetic Retinopathy Screening in Taiwan. Diabetic Medicine, 20, 727-733.
http://dx.doi.org/10.1046/j.1464-5491.2003.01019.x
[89] Foulds, W.S., McCuish, A., Barrie, T., et al. (1983) Diabetic Retinopathy in the West of Scotland: Its Detection and Prevalence, and the Cost-Effectiveness of a Proposed Screening Program. Health Bulletin, 41, 318-326.
[90] Kohner, E.M. (1978) The Evalution and Natural History of Diabetic Retinopathy. International Ophthalmology Clinics, 18, 1-16.
[91] Aiello, L.P., Gardner, T.W., King, G.L., et al. (1998) Diabetes Retinopathy. Diabetes Care, 21, 143-156.
http://dx.doi.org/10.2337/diacare.21.1.143
[92] Wilkinson, C.P., Ferris, F.L., Klein, R.E., et al. (2003) Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology, 110, 1677-1682.
http://dx.doi.org/10.1016/S0161-6420(03)00475-5
[93] Eastman, R.C., Javitt, J.C., Herman, W.H., et al. (1997) Model of Complications of NIDDM: I. Model Construction and Assumptions. Diabetes Care, 20, 725-734.
http://dx.doi.org/10.2337/diacare.20.5.725
[94] Tung, T.H., Chen, S.J., Shih, H.C., et al. (2006) Assessing the Natural Course of Diabetic Retinopathy: A Population-Based Study in Kinmen, Taiwan. Ophthalmic Epidemiology, 13, 327-333.
http://dx.doi.org/10.1080/09286580600826637
[95] Williams, R., Airey, M., Baxter, H., et al. (2004) Epidemiology of Diabetic Retinopathy and Macular Oedema: A Systematic Review. Eye, 18, 963-983.
http://dx.doi.org/10.1038/sj.eye.6701476
[96] Tung, T.H., Shih, H.C., Chen, S.J., et al. (2008) Economic Evaluation of Screening for Diabetic Retinopathy among Chinese Type 2 Diabetes: A Community-Based Study in Kinmen, Taiwan. Journal of Epidemiology, 18, 225-233.
http://dx.doi.org/10.2188/jea.JE2007439
[97] Javitt, J.C., Aiello, L.P., Bassi, L.J., et al. (1991) Detecting and Treating Retinopathy in Patients with Type 1 Diabetes Mellitus: Savings Associated with Improved Implementation of Current Guidelines. Ophthalmology, 98, 1565-1574.
http://dx.doi.org/10.1016/S0161-6420(91)32086-4
[98] Klein, R., Klein, B.E., Neider, M.W., et al. (1985) Diabetic Retinopathy as Detected Using Ophthalmoscopy, a Nonmydriatic Camera and a Standard Fundus Camera. Ophthalmology, 92, 485-491.
http://dx.doi.org/10.1016/S0161-6420(85)34003-4
[99] Maberley, D., Walker, H., Koushik, A., et al. (2003) Screening for Diabetic Retinopathy in James Bay, Ontario: A Cost-Effectiveness Analysis. Canadian Medical Association Journal, 168, 160-164.
[100] Heaven, C.J., Cansfield, J. and Shaw, K.M. (1993) The Quality of Photographs Produced by the Non-Mydriatic Fundus Camera in a Screening Programme for Diabetic Retinopathy: A 1 Year Prospective Study. Eye, 7, 787-790.
http://dx.doi.org/10.1038/eye.1993.185
[101] Ahmed, J.T.P., Ward, S.E., Bursell, L.M., et al. (2006) The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy. Diabetes Care, 29, 2205-2209.
http://dx.doi.org/10.2337/dc06-0295
[102] Hutchinson, A., Mclntosh, A., Peters, J., et al. (2000) Effectiveness of Screening and Monitoring Tests for Diabetic Retinopathy—A Systematic Review. Diabetic Medicine, 17, 495-506.
http://dx.doi.org/10.1046/j.1464-5491.2000.00250.x
[103] Vijan, S., Hofer, T.P. and Hayward, R.A. (2000) Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus. The Journal of the American Medical Association, 283, 889-896.
http://dx.doi.org/10.1001/jama.283.7.889
[104] Javitt, J.C. and Aiello, L.P. (1996) Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. Annals of Internal Medicine, 124, 164-169.
http://dx.doi.org/10.7326/0003-4819-124-1_Part_2-199601011-00017
[105] Polak, B.C., Crijns, H., Casparie, A.F., et al. (2003) Cost-Effectiveness of Glycemic Control and Ophthalmological Care in Diabetic Retinopathy. Health Policy, 64, 89-97.
http://dx.doi.org/10.1016/S0168-8510(02)00143-4
[106] Matz, H., Falk, M., Gottinger, W., et al. (1996) Cost-Benefit Analysis of Diabetic Eye Disease. Ophthalmologica, 210, 348-353.
http://dx.doi.org/10.1159/000310742
[107] Peng, C.C., Chou, P., Tung, T.H., et al. (2009) Cost-Benefit Analysis of Screening for Diabetic Retinopathy among Chinese Type 2 Diabetes: Decision from Different Perspectives of a Population-Based Study in Kinmen, Taiwan. Health, 1, 63-72.
http://dx.doi.org/10.4236/health.2009.14050
[108] The Diabetic Retinopathy Vitrectomy Study Research Group (1985) Early Vitrectomy for Severe Vitreous Hemorrhage in Diabetic Retinopathy. Two-Year Results of a Randomized Trial. DRVS Report No. 2. Archives of Ophthalmology, 103, 1644-1652.
http://dx.doi.org/10.1001/archopht.1985.01050110038020
[109] The DCCT Research Group (1986) The Diabetes Con-trol and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase. Diabetes, 35, 530-545.
http://dx.doi.org/10.2337/diab.35.5.530
[110] DCCT (1995) The Effect of Intensive Diabetes Treatment on the Progression of Diabetic Retinopathy in Insulin- Dependent-Diabetes-Mellitus. Archives of Ophthalmology, 113, 36-51.
http://dx.doi.org/10.1001/archopht.1995.01100010038019
[111] Stenkula, S. (1984) Photocoagulation in Diabetic Retinopathy. A Multicentre Study in Sweden. Acta Ophthalmologica, 162, 1-100.
[112] The Diabetic Retinopathy Study Research Group (1981) Photocoagulation Treatment of Proliferative Diabetic Retinopathy. Clinical Application of Diabetic Retinopathy Study (DRS) Findings, DRS Report Number 8. Ophthalmology, 88, 583-600.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.